{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:22:57Z","timestamp":1790511777941,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1136\/ard.61.1.32","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:29:07Z","timestamp":1027765747000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice"],"prefix":"10.1016","volume":"61","author":[{"given":"B","family":"Gudbjornsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U I","family":"Juliusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F V","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.1.32_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1136\/ard.61.1.32_bib2","unstructured":"Liljestrand G. The Nobel Prize in Physiology or Medicine 1950: \u201cfor their discoveries relating to the hormones of the adrenal cortex, their structure and biological effects\u201d. The Official Web Site of The Nobel Foundation: http:\/\/www.nobel.se\/medicine\/"},{"key":"10.1136\/ard.61.1.32_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.61.1.32_bib4","first-page":"512","article-title":"Glucocorticoids in clinical practice","volume":"32","author":"Holland","year":"1991","journal-title":"J Fam Pract"},{"key":"10.1136\/ard.61.1.32_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2710.2000.00284.x","article-title":"Is enough attention being given to the adverse effects of corticosteroid therapy?","volume":"25","author":"Hougardy","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.1136\/ard.61.1.32_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","article-title":"Epidemiology and clinical features of osteoporosis in young individuals","volume":"15","author":"Khosla","year":"1994","journal-title":"Bone"},{"key":"10.1136\/ard.61.1.32_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.54.10.801","article-title":"Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis","volume":"54","author":"Peel","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.1.32_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1136\/ard.61.1.32_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"key":"10.1136\/ard.61.1.32_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/ard.54.1.66","article-title":"Steroid induced osteoporosis: an opportunity for prevention?","volume":"54","author":"Peat","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.1.32_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2796.1998.00408.x","article-title":"A UK consensus group on management of glucocorticoid-induced osteoporosis: an update","volume":"244","author":"Eastell","year":"1998","journal-title":"J Intern Med"},{"key":"10.1136\/ard.61.1.32_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.1780391104","article-title":"Recommendation for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"39","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.1.32_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00124743-200006000-00001","article-title":"Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis","volume":"6","author":"Osiri","year":"2000","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.61.1.32_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","article-title":"Steroid-induced fractures and bone loss in patients with asthma","volume":"309","author":"Adinoff","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.1.32_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","article-title":"Population-based study of survival after osteoporotic fractures","volume":"137","author":"Cooper","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.61.1.32_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.61.1.32_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s001980050107","article-title":"The cost of treating osteoporotic fractures in the United Kingdom female population","volume":"8","author":"Dolan","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1136\/ard.61.1.32_bib18","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations","volume":"50","author":"Cushing","year":"1932","journal-title":"Bulletin of the Johns Hopkins Hospital"},{"key":"10.1136\/ard.61.1.32_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/jcem-52-5-1033","article-title":"Isolated skeletal involvement in Cushing's syndrome: response to therapy","volume":"52","author":"Hough","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.61.1.32_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem-72-2-382","article-title":"The course of biochemical parameters of bone turnover during treatment with corticosteroids","volume":"72","author":"Prummel","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.61.1.32_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/endo-122-2-482","article-title":"Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving beta-estradiol","volume":"122","author":"Goulding","year":"1988","journal-title":"Endocrinology"},{"key":"10.1136\/ard.61.1.32_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0300-595X(80)80023-5","article-title":"Drug-induced disorders of vitamin D and mineral metabolism","volume":"9","author":"Hahn","year":"1980","journal-title":"Clin Endocrinol Metab"},{"key":"10.1136\/ard.61.1.32_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.1995.tb00868.x","article-title":"Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis","volume":"237","author":"Eastell","year":"1995","journal-title":"J Intern Med"},{"key":"10.1136\/ard.61.1.32_bib24","first-page":"995","article-title":"Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: a 3-year follow-up","volume":"23","author":"Adachi","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.1.32_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.1.32_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.157.3.9703080","article-title":"Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease","volume":"157","author":"McEvoy","year":"1998","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1136\/ard.61.1.32_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/ard.45.10.852","article-title":"Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids","volume":"45","author":"Verstraeten","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.1.32_bib28","first-page":"646","article-title":"Diagnosis, prophylaxis, and treatment of osteoporosis","volume":"6","year":"1993","journal-title":"Am J Med"},{"key":"10.1136\/ard.61.1.32_bib29","first-page":"25","article-title":"Horm\u00f3namedferd kvenna, \u00cdslandi (Hormone treatment of women in Iceland)","volume":"84","author":"Eliasson","year":"1998","journal-title":"L\u00e6knabladid"},{"key":"10.1136\/ard.61.1.32_bib30","first-page":"839","article-title":"Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"49","author":"Blair","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1136\/ard.61.1.32_bib31","first-page":"279","article-title":"Glucocorticosteroid-induced osteoporosis","volume":"14","author":"Reid","year":"2000","journal-title":"Baillieres Clin Endocrinol Metab"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724094950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724094950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.1.32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T09:00:49Z","timestamp":1736067649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724094950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0003496724094950"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.1.32","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.1.32","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}